| 000 | 01011 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515055434.0 | ||
| 264 | 0 | _c20070327 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1352-4585 | ||
| 024 | 7 |
_a10.1177/1352458506071303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBifulco, M | |
| 245 | 0 | 0 |
_aFrom anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cJan 2007 |
||
| 300 |
_a133-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCannabinoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xtherapeutic use |
| 700 | 1 | _aLaezza, C | |
| 700 | 1 | _aMalfitano, A M | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 13 _gno. 1 _gp. 133-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1352458506071303 _zAvailable from publisher's website |
| 999 |
_c16854351 _d16854351 |
||